US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 13.540
  • -0.780-5.45%
Trading May 7 12:24 ET
1.61BMarket Cap-13.02P/E (TTM)

Arcutis Biotherapeutics Key Stats

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 78.261M--
--2025/Q2-- / 70.910M--
May 6, 20252025/Q165.846M / 62.480M--
Feb 25, 20252024/Q471.360M / 60.517M--
Nov 6, 20242024/Q344.755M / 37.340M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 78.261M--
--2025/Q2-- / 70.910M--
May 6, 20252025/Q165.846M / 62.480M--
Feb 25, 20252024/Q471.360M / 60.517M--
Nov 6, 20242024/Q344.755M / 37.340M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More